Infliximab for ulcerative colitis following liver transplantation

Authors:
  • ASA. Hillary Steinhart
    A. Hillary Steinhart

Abstract
Primary sclerosing cholangitis is a chronic cholestatic disease with a progressive course, often culminating in hepatic transplantation. When associated with primary sclerosing cholangitis, ulcerative colitis commonly follows a mild course before, but a more progressive course following liver transplantation, with a significant proportion of patients becoming steroid dependent and/or requiring colectomy. We report the first case demonstrating the efficacy and safety of infliximab therapy for ulcerative colitis following hepatic transplantation.

This publication has 25 references indexed in Scilit: